News
Alzheimer’s blood tests may one day allow patients and their doctors to track their individual progress in reducing risk, ...
In a new study, researchers found that type 2 diabetes can “rewire" the brain in ways similar to early Alzheimer’s disease.
An extended study after a primary trial supports using the anti-amyloid drug lecanemab (Leqembi) for up to 36 months in ...
Not getting enough of the deeper stages of sleep raises the risk of brain deterioration associated with Alzheimer’s disease, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results